Wegovy Cost: Pharmacy Pricing, Coupons, and Coverage

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub — plain-language guidance on GLP-1 therapy, metabolic health, and the genetics behind individual response.

Wegovy is prescribed specifically for chronic weight management, and that indication shapes both its price and its coverage story. As of April 2026, people searching its cost usually discover that the quoted list figure and the counter total can be worlds apart. The distance between them is set by insurance design, prior-authorization rules, savings-card eligibility, and pharmacy pricing. This guide follows the number from published list price to the amount patients in different situations actually pay.

Published list price

Wegovy lists at approximately $1,349 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing — among the higher list figures in the category. As always, list price is the pre-negotiation starting point ahead of rebates, plan discounts, manufacturer cards, and pharmacy adjustment. Most insured patients do not pay it; the real cost tracks your formulary, prior-authorization status, and the indication written.

Why the weight indication complicates coverage

Because Wegovy is a weight-management product, coverage is often the harder case. Commercial plans that readily cover GLP-1 receptor agonists for type 2 diabetes may treat chronic weight management differently — frequently requiring BMI-based prior authorization, and in some plans excluding the indication entirely. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products. Check your plan for its specific rules.

Savings options to compare

Manufacturer card

Novo Nordisk publishes a savings-card program that can substantially reduce monthly cost for eligible commercially-insured patients. Medicare, Medicaid, and TRICARE enrollees are generally excluded, and the card carries monthly and annual caps that change over time. Confirm terms on the manufacturer site before you fill.

Discount platforms

GoodRx and SingleCare publish pharmacy-specific coupon prices. Comparing pharmacies can lower a cash total, though the savings depend on location and are not guaranteed from one fill to the next.

Compounding during the shortage years

While the FDA had semaglutide and tirzepatide flagged as in shortage, 503A compounding pharmacies were permitted to prepare compounded formulations of those molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing the compounding window without ending all legitimate activity. Compounded products are not identical to FDA-approved brand medications and are priced on their own terms.

What patients tend to pay

With a covered indication and savings card applied, eligible patients may pay as little as $25 per month, within plan caps. When the indication is not covered, cash cost lands near list price minus any coupon. Uninsured patients approach list price; compounded routes through the PlexusDx Weight Management Protocols follow separate published pricing, offered as Semaglutide Injection and Semaglutide Oral.

Starting with your genetic context

Before any GLP-1 pathway protocol, the Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights, reading variants such as FTO and MC4R that shape appetite regulation and energy balance. It is educational information about your pathway biology — it does not predict response to any medication.

Related reading: Wegovy coupon, Wegovy side effects, and Oral Wegovy.

Frequently Asked Questions

How much does Wegovy cost per month?

About $1,349 per month at U.S. list price as of April 2026, per Novo Nordisk published pricing. That is the pre-insurance figure. Coverage, savings cards, and pharmacy pricing can change the counter total considerably, so verify the current amount with your pharmacy before filling.

Is Wegovy covered by insurance?

Coverage depends on the plan, formulary, the FDA indication written, and prior authorization. Because Wegovy is a weight-management product, coverage is often harder and may require BMI-based prior authorization. Medicare does not cover weight-alone indications as of April 2026. Confirm how your specific plan treats Wegovy before assuming any price.

Are savings cards available?

Novo Nordisk publishes a savings card for eligible commercially-insured patients, and platforms like GoodRx list separate discount prices. Government-insurance patients are typically excluded from the manufacturer card, so confirm current eligibility and caps on the manufacturer site at fill time.

Are there lower-cost alternatives?

Licensed compounding pharmacies prepare compounded semaglutide and tirzepatide at separate price points from brand products; these are not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with pricing published on each product page. A PlexusDx provider can discuss whether a compounded protocol fits your goals.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.